Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methimazole with or without levothyroxine for Graves hyperthyroidism
ChiCTR-TRC-12002233Phase 4Recruiting
- Sponsor
- General Hospital of Eastern Military Command
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of methimazole and levothyroxine sodium in Graves' disease (2 arms), sponsored by General Hospital of Eastern Military Command. Primary endpoints: thyroid-stimulating hormone, total triiodothyronine and 4 more. Started Mar 2011; status: recruiting.
02
Drugs
methimazolelevothyroxine sodium
03
Conditions
Graves' disease
Beyond the preview
Go deeper on ChiCTR-TRC-12002233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002233.